Health
FDA Advisory Committee Debates Sleep Peptide Safety
The FDA’s advisory committee is meeting to discuss the safety and health claims of seven peptides popular in wellness circles. The debate centers on whether these compounds should be allowed.
Coverage timeline — 2 articles
STAT News
From new hires to departures, promotions, and hires, here are the latest comings and goings in the pharma industry.
2026-07-24 15:57 UTC
MarketWatch
The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
2026-07-24 16:00 UTC